Cancer BiologybioRxivPreprint
Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugs
Lukas Wöhrl, Durdam Das, Kathrin Weidele…·Christian Werno
This study introduces PEDRA, an ex vivo drug response assay that identifies patient-specific treatment options in metastatic biopsies, outperforming prior therapies and informing immune responses.
DOI 10.64898/2026.02.06.704037